The Intravenous Immunoglobulin (IVIG) market across the 7MM was valued at around USD 7,384 million in 2025 and is expected to ...

Drug therapy is a complex process with numerous parameters modulating its success and safety. The selection of a drug and the definition of its dosage regimen, which must consider both disease and ...

CHICAGO (Reuters) - HIV infections among intravenous drug users in the United States have fallen by half in the past decade, but HIV testing is also down and risky behaviors such as needle-sharing ...

Tepezza is an intravenous medication that may help treat thyroid eye disease (TED) by addressing immune system activity behind the eyes. Possible side effects of Tepezza include hearing issues, ...

Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease. Patients ...